Keywords: ironwood, set, receive, up, 150m, almirall, linaclotide
Ironwood set to receive up to $150M from Almirall in linaclotide deal
Article | 05 May 2009
US firm Ironwood Pharmaceuticals has entered into an out-licensing agreement with Laboratorios Almirall of Spain, for European rights to develop ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
